AGIO
AGIOS PHARMACEUTICALS, INC.D4915-min delayed · EOD close34.13 −0.23% downas of 2026-09-02mkt cap $2.0B
Pharmaceutical Preparations · SIC 2834 · CIK 0001439222
Quality score
49/100
D
Growth50
Business quality0
missing: grossMargin
Financial health100
Valuation46
missing: peRatio
Computed from filed fundamentals against fixed reference bands. Not a recommendation, and not a peer percentile.
The read
Mixed picture
Highly uneven
Strongest on financial health (100), weakest on business quality (0). The composite is the mean of the sub-scores that could be computed. 2 inputs were unavailable in the filings, so the score reflects what was reported.
Revenue growth
169.4%
year over year
Earnings growth
-161.0%
year over year